|
Real-time Estimate
Cboe BZX
13:40:33 2026-08-25 EDT
|
5-day change | 1st Jan Change | ||
| 1.575 USD | +5.00% |
|
+34.35% | +3.69% |
| Market Cap | 25.01M 21.43M 20.08M 18.34M 34.62M 2.38B 34.96M 237M 92.21M 1.2B 93.91M 91.86M 3.98B | P/E 2026 * |
-2.53x | P/E 2027 * | -1.71x |
|---|---|---|---|---|---|
| Enterprise Value | 25.01M 21.43M 20.08M 18.34M 34.62M 2.38B 34.96M 237M 92.21M 1.2B 93.91M 91.86M 3.98B | EV / Sales 2026 * |
5.9x | EV / Sales 2027 * | 1.24x |
| Free-Float |
94.51% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Marker Therapeutics, Inc.
| 21-08-20 | Wall Street hoger gesloten | |
| 21-08-20 | Wall Street koerst af op hoger slot | |
| 21-08-20 | Wall Street richting lagere opening |
| 1 day | +5.00% | ||
| 1 week | +34.35% | ||
| Current month | +36.73% | ||
| 1 month | +26.64% | ||
| 3 months | +6.55% | ||
| 6 months | -0.32% | ||
| Current year | +3.69% |
| 1 week | 1.16 |  | 1.58 |
| 1 month | 1.05 | | 1.58 |
| Current year | 1.05 | | 2.46 |
| 1 year | 0.81 | | 2.46 |
| 3 years | 0.81 | | 6.8 |
| 5 years | 0.67 | | 20.5 |
| 10 years | 0.67 | | 135.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Juan Vera
CEO | Chief Executive Officer | 46 | 2023-04-30 |
| Chief Operating Officer | 36 | 2023-11-30 | |
Patricia Allison
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Juan Vera
BRD | Director/Board Member | 46 | 2018-10-16 |
Norman Eansor
CHM | Chairman | 65 | 2022-05-23 |
Steven Elms
BRD | Director/Board Member | 62 | 2019-08-05 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/17/25 | Free | Chairman | 221,741 | 1.7138% | ||
| 11/17/25 | Free | Director | 221,741 | 1.7138% | ||
| 11/17/25 | Free | Director | 221,741 | 1.7138% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.00% | +34.35% | +22.62% | -72.65% | 25.01M | |
| +1.02% | +4.95% | +3.67% | +25.46% | 51.21B | |
| -0.10% | -2.21% | +492.15% | +537.36% | 45.35B | |
| -0.58% | +7.92% | +37.78% | +18.28% | 42.84B | |
| +1.98% | +2.78% | +22.93% | +91.23% | 42.29B | |
| -2.27% | -5.67% | +14.55% | +50.34% | 32.15B | |
| -1.36% | +3.47% | +30.84% | +135.08% | 17.31B | |
| +0.36% | +1.23% | - | - | 16.55B | |
| +1.12% | +6.35% | +11.00% | +32.62% | 14.84B | |
| -0.07% | +6.91% | +81.88% | +48.95% | 14.25B | |
| Average | +0.53% | +5.68% | +79.71% | +96.29% | 27.68B | |
| Weighted average by Cap. | +0.16% | +2.90% | +105.38% | +136.21% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.24M 3.63M 3.41M 3.11M 5.87M 404M 5.93M 40.18M 15.64M 204M 15.93M 15.58M 676M | 20.19M 17.3M 16.21M 14.8M 27.94M 1.92B 28.22M 191M 74.42M 971M 75.79M 74.14M 3.22B |
| Net income | -11.84M -10.14M -9.5M -8.68M -16.38M -1.13B -16.54M -112M -43.64M -569M -44.44M -43.47M -1.89B | -18.09M -15.5M -14.53M -13.27M -25.04M -1.72B -25.29M -171M -66.7M -870M -67.93M -66.45M -2.88B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-25 | US$1.545 | +3.00% | 98,437 |
| 26-08-24 | US$1.500 | +7.91% | 238,044 |
| 26-08-21 | US$1.390 | +13.93% | 99,375 |
| 26-08-20 | US$1.220 | -5.43% | 80,602 |
| 26-08-19 | US$1.290 | +12.17% | 232,159 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MRKR Stock
Select your edition
All financial news and data tailored to specific country editions
